BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34811512)

  • 1. Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity.
    He JY; Hong Q; Chen BX; Cui SY; Liu R; Cai GY; Guo J; Chen XM
    Acta Pharmacol Sin; 2022 Feb; 43(2):342-353. PubMed ID: 34811512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
    Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
    Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mitochondrial fission protects podocytes from albumin-induced cell damage in diabetic kidney disease.
    Tagaya M; Kume S; Yasuda-Yamahara M; Kuwagata S; Yamahara K; Takeda N; Tanaka Y; Chin-Kanasaki M; Nakae Y; Yokoi H; Mukoyama M; Ishihara N; Nomura M; Araki SI; Maegawa H
    Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166368. PubMed ID: 35202791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury.
    Hong Q; Zhang L; Das B; Li Z; Liu B; Cai G; Chen X; Chuang PY; He JC; Lee K
    Kidney Int; 2018 Jun; 93(6):1330-1343. PubMed ID: 29477240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
    Zhang M; Liu M; Xiong M; Gong J; Tan X
    J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
    Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
    Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
    Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759.
    Jin J; Zhang Z; Chen J; Liu Y; Chen Q; Wang Q
    Cell Cycle; 2019 Nov; 18(22):3125-3136. PubMed ID: 31564202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte-specific knockin of PTEN protects kidney from hyperglycemia.
    Wang H; Feng Z; Xie J; Wen F; Jv M; Liang T; Li J; Wang Y; Zuo Y; Li S; Li R; Li Z; Zhang B; Liang X; Liu S; Shi W; Wang W
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1096-F1107. PubMed ID: 29361670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragalus membranaceus and Panax notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats.
    Zhai R; Jian G; Chen T; Xie L; Xue R; Gao C; Wang N; Xu Y; Gui D
    J Diabetes Res; 2019; 2019():1602892. PubMed ID: 31179338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
    Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes.
    Li X; Cai W; Lee K; Liu B; Deng Y; Chen Y; Zhang X; He JC; Zhong Y
    Sci Rep; 2017 Nov; 7(1):14603. PubMed ID: 29097815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
    Zhan H; Jin J; Liang S; Zhao L; Gong J; He Q
    Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osmolarity and glucose differentially regulate aldose reductase activity in cultured mouse podocytes.
    Lewko B; Latawiec E; Maryn A; Barczyńska A; Pikuła M; Zieliński M; Rybczyńska A
    Exp Diabetes Res; 2011; 2011():278963. PubMed ID: 22253613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressed ER-associated degradation by intraglomerular cross talk between mesangial cells and podocytes causes podocyte injury in diabetic kidney disease.
    Fujimoto D; Kuwabara T; Hata Y; Umemoto S; Kanki T; Nishiguchi Y; Mizumoto T; Hayata M; Kakizoe Y; Izumi Y; Takahashi S; Mukoyama M
    FASEB J; 2020 Nov; 34(11):15577-15590. PubMed ID: 32996639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An adjustment in BMP4 function represents a treatment for diabetic nephropathy and podocyte injury.
    Fujita Y; Tominaga T; Abe H; Kangawa Y; Fukushima N; Ueda O; Jishage KI; Kishi S; Murakami T; Saga Y; Kanwar YS; Nagai K; Doi T
    Sci Rep; 2018 Aug; 8(1):13011. PubMed ID: 30158674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating metabolomics and network pharmacology to investigate Panax japonicus prevents kidney injury in HFD/STZ-induced diabetic mice.
    Wang T; Huang X; Zhai K; Yu J; Li J; Duan H; Liu J; Lu Z; Guo J; Li F
    J Ethnopharmacol; 2023 Mar; 303():115893. PubMed ID: 36368565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-4645-3p attenuates podocyte injury and mitochondrial dysfunction in diabetic kidney disease by targeting Cdk5.
    Zhang Y; Xia S; Tian X; Yuan L; Gao Y; Liu D; Qi H; Wang S; Liu Z; Li Y; Zhao Z; Liu W
    FASEB J; 2024 May; 38(10):e23668. PubMed ID: 38742811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy.
    Jung E; Kim J; Ho Kim S; Kim S; Cho MH
    Eur J Pharmacol; 2015 Aug; 761():116-24. PubMed ID: 25977232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.